Novel KCNA5 mutation implicates tyrosine kinase signaling in human atrial fibrillation
- 31 May 2010
- journal article
- research article
- Published by Elsevier in Heart Rhythm
- Vol. 7 (9) , 1246-1252
- https://doi.org/10.1016/j.hrthm.2010.05.032
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Can inhibition of IKur promote atrial fibrillation?Heart Rhythm, 2008
- Cardiac Sodium Channel ( SCN5A ) Variants Associated with Atrial FibrillationCirculation, 2008
- Prolonged Signal-Averaged P-Wave Duration as an Intermediate Phenotype for Familial Atrial FibrillationJournal of the American College of Cardiology, 2008
- Genetics of atrial fibrillation: Rare mutations, common polymorphisms, and clinical relevanceHeart Rhythm, 2007
- Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillationHeart Rhythm, 2007
- Familial aggregation in lone atrial fibrillationHuman Genetics, 2005
- A Kir2.1 gain-of-function mutation underlies familial atrial fibrillationBiochemical and Biophysical Research Communications, 2005
- Requirement of Activation of the Extracellular Signal-regulated Kinase Cascade in Myocardial Cell HypertrophyJournal of Molecular and Cellular Cardiology, 2000
- Association of Src Tyrosine Kinase with a Human Potassium Channel Mediated by SH3 DomainScience, 1996
- Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase InhibitorJournal of Biological Chemistry, 1996